Maximon
- Company typePrivate
- Founded2021
- HeadquartersZug, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
Maximon firmographics
Firmographics- Name
- Maximon
- Legal name
- Maximon AG
- Website
- https://maximon.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Maximon industry classification
Industry- Product category
- Longevity Company Building and Venture Investment
- NAICS
- Corporate, Subsidiary, and Regional Managing Offices (551114), Continuing Care Retirement Communities (623311)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK)
- akta.pro secondary industry
- Healthy Aging & Cognitive Support Supplements (CRADAGAM)
Keywords
Where Maximon is headquartered
LocationHeadquarters
- HQ city
- Zug
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Maximon business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Company Builder Equity Stakes: Maximon builds and operationalizes longevity companies from scratch, taking equity stakes in portfolio companies. As companies become operational and profitable (e.g., Avea Life reaching profitability), Maximon benefits through equity appreciation and potential exits.
- Longevity Co-Investment Fund Management: Maximon manages the Longevity Co-Investment Fund (LCIF) targeting CHF 100 million with minimum tickets of CHF 500,000 for qualified investors. Additional investment vehicle launched January 2024 for qualified investors. Revenue derived from management fees and carried interest.
- Actively Managed Certificate (AMC): Partnership with Marcuard Heritage and GenTwo to offer an AMC structure allowing professional investors access to Maximon's longevity portfolio starting at CHF 10,000, democratizing longevity investments.
- Longevity Clinic Services: Portfolio company AYUN operates a longevity clinic in Zurich offering subscription-based health services including comprehensive check-ups, biomarker analysis, and personalized longevity programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Longevity Co-Investment Fund (LCIF) for qualified institutional investors |
| Subscription | Annual | Actively Managed Certificate (AMC) for professional investors |
| Subscription | Monthly | AYUN Longevity Clinic subscription services |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Maximon product offering
Product offeringCore offering
Maximon is a longevity company builder that identifies promising business opportunities in the healthy aging and rejuvenation sector and builds companies from scratch, providing funding, operational infrastructure, HR support, and a curated ecosystem. The company also manages the Longevity Co-Investment Fund (LCIF) with a CHF 100 million target volume for institutional investors, and operates portfolio companies spanning supplements, longevity clinics, women's health, and senior living.
Product overview
Maximon is a longevity company builder that identifies business opportunities in the longevity field and builds companies from scratch. The company operates as a platform with multiple portfolio ventures at various stages: operational companies (Evidence-Based Longevity Supplements, Data-Driven Health Analytics, Avea Life), launching ventures (LIV Lounge, Senior Co-Living, AYUN clinic), and stealth projects (Maximon X). Key offerings include AYUN (longevity clinic), Avea Life (supplements), Frieda Health (women's health platform), alongside investment vehicles like the Longevity Co-Investment Fund and the annual Longevity Investors Conference. Maximon provides proven structures, financing, and an ecosystem for entrepreneurs building longevity ventures.
Differentiator
Problem solved
Functional benefit
Brands
- AVEA: Evidence-based longevity supplements company
- AYUN
- Frieda Health
- Longevity Investors Conference
- Longevity Co-Investment Fund (LCIF)
Products and services
- Evidence-Based Longevity Supplements (AVEA) A portfolio venture (AVEA) developing and commercializing evidence-based dietary supplements targeted at extending healthspan and promoting healthy aging. Includes Collagen Activator formula and other longevity supplements for health-conscious consumers and corporate partners like SailGP German Team.
- AYUN Longevity Clinic A portfolio venture (AYUN) operating a longevity clinic in Zurich offering personalized health assessments, preventive medicine services, biomarker analysis, and personalized longevity programs on a subscription basis. Particularly popular among financial sector professionals seeking health optimization.
- Frieda Health Digital Platform A portfolio venture (Frieda Health) providing a digital health platform focused on women's health, particularly for women aged 45+ during menopause. Raised EUR 2.5 million in pre-seed funding from Maximon.
- Longevity Co-Investment Fund (LCIF) A co-investment fund with target volume of CHF 100 million for longevity ventures. Minimum ticket of CHF 500,000 for direct investment, with an actively managed certificate (AMC) option starting at CHF 10,000 for professional investors via the Marcuard Heritage and GenTwo partnership.
- Data-Driven Health Analytics A portfolio venture (operational status) providing data analytics solutions for health insights and longevity optimization.
- Senior Co-Living A portfolio venture (launching status) focused on co-living solutions for active and healthy seniors, addressing housing and community needs for the longevity society.
- LIV Lounge A portfolio venture (launching status) focused on longevity services within the Maximon ecosystem.
Quantifiable outcome
- Avea Life growing at 300-400% annually and already profitable within 2.5 years of market entry
- +2 more outcomes
Companies that use Maximon
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
Maximon technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Maximon partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Health2Wealth AssociationminorAYUN partnered with Health2Wealth Association for a longevity networking event, expanding reach to health and wellness professionals and enthusiasts.
- SailGP German TeamminorAVEA became Official Supplier of the SailGP German Team, demonstrating B2B enterprise adoption of longevity supplements for athletic performance optimization.
- Eat by AlexminorAvea partnered with Eat by Alex to infuse Avea's Collagen Activator formula into a special version of their clean plant protein powder, expanding product distribution.
- XPRIZEcoreLongevity Investors partnered with XPRIZE for the Investor Summit, creating an exclusive partnership to connect investors with XPRIZE healthspan competition and longevity research initiatives.
- GenTwocoreSwiss fintech company GenTwo provided the assetization platform enabling Marcuard Heritage to make Maximon's Longevity Fund bankable, investible, and accessible to professional clients.
- BiolyticacoreBiolytica co-organized the Longevity Investors Lunch Davos 2023 alongside Maximon and Longevity Investors Conference. Biolytica's CEO Rob Konrad Maciejewski served as co-host.
- Deep Knowledge GroupminorDeep Knowledge Group sponsored the Longevity Investors Lunch Davos 2022 and provided keynote presentation on longevity industry overview and Swiss Longevity Valley.
- National University of Singapore (NUS)minorNUS sponsored the Davos 2023 event, with Dr. Brian Kennedy serving as Director of Centre for Healthy Longevity at NUS and presenting on longevity research.
Scale indicators6 records
Recent moves7 records
Expansion highlights7 records
Maximon competitors and assessment
Company assessmentDirect peers
- LongeVC: A dedicated early-stage longevity-focused venture fund backed by Michael Antonov; directly comparable to Maximon's LCIF as a thematic longevity investor, though structured as a pure fund rather than a company builder.
- The Longevity Fund: A venture fund investing in longevity and healthspan startups; comparable to Maximon's LCIF mandate, with a similar target of seed/early-stage healthy-aging companies.
- Longevity Vision Fund: A hybrid VC/accelerator focused on longevity ventures founded by Sergey Young; overlaps with Maximon as a longevity-focused investor and ecosystem builder hosting conferences and community events.
- Elysium Health: Evidence-based longevity supplement company built around NAD+ science with a strong scientific advisory board; directly comparable to Maximon's AVEA supplements portfolio in product, science-led positioning, and channel.
- Apollo Health Ventures: European venture fund investing in longevity science and biotech; comparable thematic focus to Maximon's LCIF but with a biotech-rather-than-D2C/supplements portfolio emphasis.
Emerging players
- Fountain Life: Operates longevity/preventive-health clinics and a consumer supplement line; comparable to Maximon's AYUN clinic and AVEA supplements portfolio but as a single integrated operator rather than a multi-venture builder.
- Human Longevity Inc. Founded by Peter Diamandis/Craig Venter to deliver data-driven preventive longevity diagnostics and care; overlaps with Maximon's AYUN clinic and Data-Driven Health Analytics venture.
- InsideTracker: Biomarker-driven personalized health and longevity platform with consumer subscription products; comparable to Maximon's AYUN biomarker-led longevity offerings and Data-Driven Health Analytics venture.
Broad incumbents
- Redesign Health: US healthcare company builder that launches multiple health ventures per year; analogous business model to Maximon but with much greater scale, broader health verticals, and US-centric operations.
Others
- Swiss Longevity Science Association: Swiss industry association promoting longevity research and ecosystem development; thematically related to Maximon's positioning as a Swiss longevity ecosystem leader and organizer of the Longevity Investors Conference.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Maximon social profiles
Digital presenceMaximon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Maximon leadership team
Management profileNumber of profiles
Profiles15 records
Maximon subsidiaries and ownership
Company hierarchySubsidiaries6 records
Maximon funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Maximon M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Maximon
What does Maximon do?
Maximon is a longevity company builder that identifies promising business opportunities in the healthy aging and rejuvenation sector and builds companies from scratch, providing funding, operational infrastructure, HR support, and a curated ecosystem. The company also manages the Longevity Co-Investment Fund (LCIF) with a CHF 100 million target volume for institutional investors, and operates portfolio companies spanning supplements, longevity clinics, women's health, and senior living.
Is Maximon a public or private company?
Maximon is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Maximon founded?
Maximon was founded in 2021. It employs 11 to 50 people.
Where is Maximon based?
Maximon is headquartered in Zug, Switzerland, in the Europe region.
How does Maximon make money?
Four revenue lines are on record. Company Builder Equity Stakes are the primary driver. The others are longevity Co-Investment Fund Management, actively Managed Certificate (AMC) and longevity Clinic Services.
Who are Maximon's main competitors?
Direct peers on record are LongeVC, The Longevity Fund, Longevity Vision Fund, Elysium Health and Apollo Health Ventures. Emerging players are Fountain Life, Human Longevity Inc. and InsideTracker. Redesign Health is listed as a broad incumbent. Swiss Longevity Science Association is listed as an others.
Does Maximon have an API?
No public API is recorded for Maximon.
What industry is Maximon in?
Maximon's product category is Longevity Company Building and Venture Investment. Its primary akta.pro industry code is HSADAGAK, Healthy Aging & Longevity Lifestyle Coaching, with a secondary code of CRADAGAM, Healthy Aging & Cognitive Support Supplements. Its NAICS code is 551114 and its SIC code is 8742.